ARCT
ARCT
US03969T1097
Arcturus Therapeutics Holdings
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
390.53M EUR
191M EUR
219.43M EUR
174.18M EUR
Enterprise Value
197.25M EUR
22.45M EUR
32.04M EUR
-31.73M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-3.71x
--
--
--
Price to Sales
13.3x
10.2x
5.18x
4.17x
Price to Book
2.27x
1.11x
1.15x
0.81x
EV/Revenue
6.72x
1.2x
0.76x
-0.76x
EV/EBITDA
-1.98x
--
--
--
Price to FCF (P/FCF)
20.28x
--
--
--
EV/FCF
10.24x
--
--
--
FCF Yield
4.93%
-38.13%
-26.74%
-22.52%
ende